Dosidal · Switzerland

Dafalgan Direct, Granulat

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68622 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68622
atc: N02BE01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2022-12-23
term: zugelassen
valid_until: 2027-12-22
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: N02BE01
authorisation_number: 68622
form: GRAO
holder: UPSA Switzerland AG
holder_partner_nr: 1103220
it_number: 01.01.1.
name: Dafalgan Direct, Granulat
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
Zp_-taBHLr8O3JKAUS6HTWQJixWR0PgrfuEwsIf3B6i-agXWdtKBmqEBv93MN-znR93FwFAxqqjg8Wa6nFhFUA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68622 · Related records in other markets · Dosidal